QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)

Illumina (ILMN) Stock Forecast, Price & News

$133.30
+4.39 (+3.41%)
(As of 09/27/2023 ET)
Compare
Today's Range
$130.02
$133.58
50-Day Range
$128.91
$192.44
52-Week Range
$127.37
$248.87
Volume
2.59 million shs
Average Volume
1.44 million shs
Market Capitalization
$21.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$236.05

Illumina MarketRank™ Forecast

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
77.1% Upside
$236.05 Price Target
Short Interest
Healthy
3.76% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.11
Upright™ Environmental Score
News Sentiment
0.82mentions of Illumina in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$178,560 Sold Last Quarter
Proj. Earnings Growth
193.98%
From $0.83 to $2.44 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.82 out of 5 stars

Medical Sector

67th out of 976 stocks

Analytical Instruments Industry

5th out of 27 stocks


ILMN stock logo

About Illumina (NASDAQ:ILMN) Stock

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

ILMN Price History

ILMN Stock News Headlines

Summiting Italy’s Stelvio Pass for Cancer Research
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Is the Worst Over for Illumina Stock?
Illumina Inc ILMN Stock Quote
PRESS DIGEST- Financial Times - Sept. 6
Illumina Names New Chief Executive
Why Is Illumina Stock Trading Lower Today?
Illumina: Genetic Plot Twist, Time To Unravel The Stock
Illumina: Genetic Plot Twist, Time To Unravel The Stock
11 Analysts Have This to Say About Illumina
See More Headlines
Receive ILMN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Illumina and its competitors with MarketBeat's FREE daily newsletter.

ILMN Company Calendar

Last Earnings
8/09/2023
Today
9/27/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
Sector
Medical
Current Symbol
NASDAQ:ILMN
CUSIP
45232710
Employees
10,260
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$236.05
High Stock Price Forecast
$350.00
Low Stock Price Forecast
$150.00
Forecasted Upside/Downside
+79.5%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
16 Analysts

Profitability

Net Income
$-4,404,000,000.00
Pretax Margin
-89.80%

Debt

Sales & Book Value

Annual Sales
$4.58 billion
Cash Flow
$4.64 per share
Book Value
$41.95 per share

Miscellaneous

Free Float
158,094,000
Market Cap
$20.82 billion
Optionable
Optionable
Beta
1.12

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Joydeep Goswami M.B.A. (Age 52)
    Ph.D., CFO, Chief Strategy & Corp. Devel. Officer
    Comp: $787.3k
  • Ms. Susan H. TousiMs. Susan H. Tousi (Age 54)
    Chief Commercial Officer
    Comp: $790.2k
  • Mr. Charles E. Dadswell Esq. (Age 64)
    Interim CEO & Gen. Counsel
  • Stephanie Campos
    Pres
  • Mr. Kevin Carl Pegels (Age 56)
    Chief of Global Operations
  • Mr. Scott Ericksen (Age 51)
    VP & Chief Accounting Officer
  • Dr. Steven Barnard Ph.D.
    Chief Technology Officer
  • Ms. Carissa L. Rollins (Age 53)
    Chief Information Officer
  • Ms. Sallilyn Schwartz
    VP of Investor Relations
  • Ms. Kathryne Gambrell Reeves (Age 54)
    Chief Marketing Officer













ILMN Stock - Frequently Asked Questions

Should I buy or sell Illumina stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Illumina in the last year. There are currently 2 sell ratings, 6 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ILMN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ILMN, but not buy additional shares or sell existing shares.
View ILMN analyst ratings
or view top-rated stocks.

What is Illumina's stock price forecast for 2023?

16 brokers have issued 12 month target prices for Illumina's shares. Their ILMN share price forecasts range from $150.00 to $350.00. On average, they anticipate the company's stock price to reach $236.05 in the next year. This suggests a possible upside of 79.5% from the stock's current price.
View analysts price targets for ILMN
or view top-rated stocks among Wall Street analysts.

How have ILMN shares performed in 2023?

Illumina's stock was trading at $202.20 at the beginning of the year. Since then, ILMN shares have decreased by 35.0% and is now trading at $131.50.
View the best growth stocks for 2023 here
.

Are investors shorting Illumina?

Illumina saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 5,950,000 shares, an increase of 5.5% from the August 31st total of 5,640,000 shares. Based on an average daily volume of 1,560,000 shares, the days-to-cover ratio is currently 3.8 days.
View Illumina's Short Interest
.

When is Illumina's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our ILMN earnings forecast
.

How were Illumina's earnings last quarter?

Illumina, Inc. (NASDAQ:ILMN) announced its earnings results on Wednesday, August, 9th. The life sciences company reported $0.32 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.30. The life sciences company earned $1.18 billion during the quarter, compared to the consensus estimate of $1.16 billion. Illumina had a positive trailing twelve-month return on equity of 1.97% and a negative net margin of 93.86%. The company's quarterly revenue was up 1.2% on a year-over-year basis. During the same period last year, the firm earned $0.57 EPS.
Read the conference call transcript
.

What guidance has Illumina issued on next quarter's earnings?

Illumina issued an update on its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of $0.75-$0.90 for the period, compared to the consensus EPS estimate of $1.31. The company issued revenue guidance of $4.63 billion-$4.63 billion, compared to the consensus revenue estimate of $4.91 billion.

What is Francis deSouza's approval rating as Illumina's CEO?

496 employees have rated Illumina Chief Executive Officer Francis deSouza on Glassdoor.com. Francis deSouza has an approval rating of 92% among the company's employees. This puts Francis deSouza in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Illumina own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Illumina investors own include NVIDIA (NVDA), Alibaba Group (BABA), Tesla (TSLA), Netflix (NFLX), Walt Disney (DIS), PayPal (PYPL), Salesforce (CRM), Adobe (ADBE), Visa (V) and Micron Technology (MU).

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

Who are Illumina's major shareholders?

Illumina's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (8.84%), Geode Capital Management LLC (2.20%), Bank of New York Mellon Corp (2.17%), Alliancebernstein L.P. (1.98%), Northern Trust Corp (1.08%) and Veritas Asset Management LLP (0.96%). Insiders that own company stock include Aimee L Hoyt, Alexander Aravanis, Charles Dadswell, Francis A Desouza, Jay T Flatley, Karen K Mcginnis, Mostafa Ronaghi, Phillip G Febbo, Susan H Tousi and Susan H Tousi.
View institutional ownership trends
.

How do I buy shares of Illumina?

Shares of ILMN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Illumina's stock price today?

One share of ILMN stock can currently be purchased for approximately $131.50.

How much money does Illumina make?

Illumina (NASDAQ:ILMN) has a market capitalization of $20.82 billion and generates $4.58 billion in revenue each year. The life sciences company earns $-4,404,000,000.00 in net income (profit) each year or ($26.61) on an earnings per share basis.

How many employees does Illumina have?

The company employs 10,260 workers across the globe.

Does Illumina have any subsidiaries?
The following companies are subsidiares of Illumina: Advanced Liquid Logic Inc., Affomix Corporation, BlueBee, BlueBee Belgium BVBA, BlueBee Holding BV, BlueGnome Ltd, BlueGnome Ltd., Conexio Genomics, Conexio Genomics Pty Ltd., Edico Genome, Emedgene Inc., Emedgene Technologies Ltd, Enancio, Enancio SAS, Epicentre Biotechnologies, GRAIL LLC, GenoLogics, Grail, Helixis, Illumina (China) Scientific Co Ltd, Illumina AB, Illumina Australia Pty. Ltd., Illumina Belgium BVBA, Illumina Brasil Produtos de Biotecnologia Ltda., Illumina Cambridge Ltd., Illumina Canada ULC, Illumina Denmark ApS, Illumina Finland Oy, Illumina France Sarl, Illumina GmbH, Illumina Hong Kong Limited, Illumina India Biotechnology Private Limited, Illumina Ireland Commercial Limited, Illumina Italy S.r.l., Illumina K.K. Japan, Illumina Korea Ltd., Illumina Netherlands B.V., Illumina New Zealand Limited, Illumina Norway AS, Illumina Productos de Espana S.L.U., Illumina Rus LLC, Illumina Shanghai (Trading) Co Ltd Beijing Branch, Illumina Shanghai (Trading) Co. Ltd., Illumina Singapore Pte. Ltd., Illumina Software Inc., Illumina Switzerland GmbH, Illumina US Manufacturing Operations Inc., Liquid Logic, Moleculo, NextBio, Solexa, Verinata Health, Verinata Health Inc., and thromboDx BV.
Read More
How can I contact Illumina?

Illumina's mailing address is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. The official website for the company is www.illumina.com. The life sciences company can be reached via phone at (858) 202-4500, via email at ir@illumina.com, or via fax at 858-202-4766.

This page (NASDAQ:ILMN) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -